Darzalex Faspro (daratumumab and hyaluronidase-fihj (human recombinant))

**Product type:** Human Prescription Drug

**Active ingredient:** DARATUMUMAB; HYALURONIDASE (HUMAN RECOMBINANT)

**Strength:** 1800; 30000 mg/15mL; U/15mL

**Dosage form:** Injection

**Route:** Subcutaneous

**Labeler:** Janssen Biotech, Inc.

**Marketing category:** BLA (BLA761145)

**Pharmacologic class:** Antibodies, Monoclonal [CS], CD38-directed Antibody Interactions [MoA], CD38-directed Cytolytic Antibody [EPC], Endoglycosidase [EPC], Glycoside Hydrolases [CS]